The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy.
Yuan J, Dong X, Yap J, Hu J. · 2020
Read The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy. by Yuan J, Dong X, Yap J, Hu J. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7433213.txt.
Introduction
Yuan and co-authors review how two cell signal paths, MAPK and AMPK, interact in cancer. The MAPK path is among the best defined in cancer biology. Its overdrive drives over 40% of human cancer cases.
Active MAPK signaling turns on growth genes and blocks AMPK, a key node for cell energy control. That block helps cancer cells bear metabolic stress. New work shows AMPK can push back and tune MAPK by marking RAF and KSR proteins. This two-way talk affects how targeted drugs perform. The authors discuss pairing MAPK blockers with AMPK modulators. Such pairs could form a fresh treatment strategy for cancers driven by this pathway.
Catalog record
| CREATOR | Yuan J, Dong X, Yap J, Hu J. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 110 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |